Characterization and discrimination of spike protein in SARS‐CoV‐2 virus‐like particles via surface‐enhanced Raman spectroscopy
Biotechnology Journal · 2024
DOI: 10.1002/biot.202300191 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Journal, 2024. Verfasst von Munevver Akdeniz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Erciyes University, Kayseri, Turkey. Hauptthemen laut MEDLINE: COVID-19, Communicable Diseases, HIV Infections. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Bilimsel Araştırma Projeleri, Erciyes Üniversitesi.
Abstract (Originalsprache)
Non‐infectious virus‐like particles (VLPs) are excellent structures for development of many biomedical applications such as drug delivery systems, vaccine production platforms, and detection techniques for infectious diseases including SARS‐CoV‐2 VLPs. The characterization of biochemical and biophysical properties of purified VLPs is crucial for development of detection methods and therapeutics. The presence of spike (S) protein in their structure is especially important since S protein induces immunological response. In this study, development of a rapid, low‐cost, and easy‐to‐use technique for both characterization and detection of S protein in the two VLPs, which are SARS‐CoV‐2 VLPs and HIV‐based VLPs was achieved using surface‐enhanced Raman spectroscopy (SERS). To analyze and classify datasets of SERS spectra obtained from the VLP groups, machine learning classification techniques including support vector machine (SVM), k‐nearest neighbors (kNN), and random forest (RF) were utilized. Among them, the SVM classification algorithm demonstrated the best classification performance for SARS‐CoV‐2 VLPs and HIV‐based VLPs groups with 87.5% and 92.5% accuracy, respectively. This study could be valuable for the rapid characterization of VLPs for the development of novel therapeutics or detection of structural proteins of viruses leading to a variety of infectious diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Erciyes University, Kayseri, Turkey.
- Nanothera Lab, Drug Application and Research Center (ERFARMA), Erciyes University, Kayseri, Turkey.
- Department of Chemical Engineering, University of Massachusetts, Lowell, Massachusetts, USA.
- Koç University Research Center for Translational Medicine (KUTTAM), Koç University, Istanbul, Turkey.
- McGovern Institute for Brain Research at MIT, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
- Clinical Engineering Research and Implementation Center (ERKAM), Erciyes University, Kayseri, Turkey.
ORCID-Profile: Omer Aydin
Förderung
- Bilimsel Araştırma Projeleri, Erciyes Üniversitesi
Zitieren
APA
Akdeniz, M., Al-Shaebi, Z., Altunbek, M., Bayraktar, C., Kayabolen, A., Bagci-Onder, T., & Aydin, O. (2024). Characterization and discrimination of spike protein in SARS‐CoV‐2 virus‐like particles via surface‐enhanced Raman spectroscopy. Biotechnology Journal. https://doi.org/10.1002/biot.202300191
Vancouver
Akdeniz M, Al-Shaebi Z, Altunbek M, Bayraktar C, Kayabolen A, Bagci-Onder T, et al. Characterization and discrimination of spike protein in SARS‐CoV‐2 virus‐like particles via surface‐enhanced Raman spectroscopy. Biotechnology Journal. 2024. doi:10.1002/biot.202300191
BibTeX
@article{Akdeniz2024,
author = {Akdeniz, Munevver and Al-Shaebi, Zakarya and Altunbek, Mine and Bayraktar, Canan and Kayabolen, Alisan and Bagci-Onder, Tugba and Aydin, Omer},
title = {Characterization and discrimination of spike protein in SARS‐CoV‐2 virus‐like particles via surface‐enhanced Raman spectroscopy},
journal = {Biotechnology Journal},
year = {2024},
doi = {10.1002/biot.202300191}
}
EUVIMED